MAPT and Alzheimer disease: A combined 7 T post-mortem in situ volumetric study, supplemented by a post-mortem stereological investigation on serial gallocyanin and hyperphosphorylated tau immunohistochemically stained sections of the same brains, could answer the question as to whether longitudinal voxel-based morphometric studies are a replicable and reliable marker of AD progression.